Sygnature Discovery > Drug Discovery > DMPK and Physical Sciences > In Vivo Pharmacokinetics

In Vivo Pharmacokinetics

At Sygnature Discovery we offer services to support your non-GLP in vivo Pharmacokinetics studies in preclinical species including the planning of these studies and the analysis of any samples generated by UPLC-MS.

Following storage of samples at either -20 °C or -80 °C, samples will be prepared and then analysed. A calibration curve with a minimum of 8 calibration standards and independent Quality Control (QC) samples are included. The analysis of dose formulation concentrations is included where required as part of our service.

All data generated will be shared in a summary spreadsheet which includes calculated PK parameters where required.

In vivo pharmacokinetic reports include all raw data, calculations and a summary table with calculated paraments and notes highlighting any suggestions or issues encountered. All typical PK parameters such as clearance, volume of distribution, AUC, half-life (T1/2), Cmax, Tmax and bioavailability are calculated using WinNonlin or equivalent software, following the industry standard for NCA and PK/PD Modeling and Simulation.

 

 

 

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.

Other Related Services

In Vitro ADME

The assessment of the Absorption, Distribution, Metabolism, and Excretion (ADME) properties of compounds is a critical component is supporting the development of compounds within Discovery and Development. 

DISCOVER

Physicochemical Profiling

It is well understood that poor physicochemical properties are associated with increased failure of drug candidates within the pre-clinical and clinical development process. Assessing these parameters during the discovery optimisation process is critical.

DISCOVER

PK and Bioanalysis

Sygnature Discovery offers a range of pharmacokinetics, bioanalysis and metabolite identification services adapted to each project needs. Our experience is complemented with a suite of state-of-the art bioanalytical and metabolic identification mass spectrometry equipment.

DISCOVER

IVIVE and Human PK Predictions

The DMPK team at Sygnature Discovery has several years of experience in PK modelling and simulation. In complement to our in vitro and in vivo ADME laboratory-based services, we also offer several IVIVE and PK prediction packages to support the various stages of the drug discovery process from screening, to selection and to election of a pre-clinical drug candidate.

DISCOVER

DMPK Consultancy

Sygnature Discovery offers a range of DMPK consultancy services to drug discovery research teams within the academic, pharmaceutical, biotechnology, charity and CRO sectors as well as to life science venture capital funds.

DISCOVER